Norleucine as a replacement for methionine in phosphatase-resistant linear and cyclic peptides which bind to p85 SH2 domains

This publication has 21 references indexed in Scilit:

• Nonhydrolyzable Phosphotyrosyl Mimetics for the Preparation Of Phosphatase-Resistant SH2 Domain Inhibitors
  Biochemistry, 1994
• Protein‐tyrosine kinases: Potential targets for anticancer drug development
  The International Journal of Cell Cloning, 1994
• SH2 and SH3 domains
  Current Biology, 1993
• New Intracellular Targets for Therapeutic Drug Design
  Science, 1993
• Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding
  Biochemistry, 1993
• The assembly of signalling complexes by receptor tyrosine kinases
  BioEssays, 1993
• Cell-signaling targets for antitumour drug development
  Cancer Chemotherapy and Pharmacology, 1993
• Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways
  Cell, 1992
• Preparation of 4-[Bis(tert-butoxy)phosphorylmethyl]-N-(fluoren-9-ylmethoxycarbonyl)-DL-phenylalanine. A Hydrolytically Stable Analogue ofO-Phosphotyrosine Potentially Suitable for Peptide Synthesis
  Synthesis, 1991
• Phosphorylation of middle T by pp60c-src: A switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis
  Cell, 1989